Meridian Bioscience Inc
NASDAQ:VIVO
Meridian Bioscience Inc
NASDAQ:VIVO
Price:
33.97 USD
Market Closed
Updated:
Apr 27, 2024
Section:
Relative Value
There is not enough data to reliably calculate the relative value of VIVO.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
VIVO
Relative Value
Base Case
Not Available
Valuation Multiples
Multiples Across Competitors
VIVO Competitors Multiples
Meridian Bioscience Inc Competitors
Meridian Bioscience Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Meridian Bioscience Inc
NASDAQ:VIVO
|
1.5B USD | 4.5 | 35 | 15.5 | 18.9 | |
| JP |
|
Hoya Corp
TSE:7741
|
6.4T JPY | 8.6 | 38.5 | 23.4 | 28.9 | |
| CH |
|
Alcon AG
SIX:ALC
|
35.5B CHF | 4.1 | 40 | 17.8 | 36.2 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
194.1B DKK | 7.8 | 39.9 | 26.2 | 30.4 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
23.2B USD | 6 | 52.1 | 27.8 | 33.8 | |
| US |
|
Cooper Companies Inc
NYSE:COO
|
17.7B USD | 4.8 | 60.7 | 22.3 | 37.8 | |
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
14.3T KRW | 333.3 | -75.6 | -123.3 | -113.7 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
55.1B CNY | 14 | 33.3 | 29 | 29 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
5.3B GBP | 3.1 | 50.7 | 46.8 | 50.9 | |
| US |
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
6.3B USD | 1.6 | -48 | 12.2 | 26.3 | |
| CA |
B
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.2B USD | 1.3 | -20 | 15.8 | 44.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
